Matthijs van der Meulen,Maarten M J Wijnenga
Matthijs van der Meulen
Background and purpose: Training and education is essential for best practice medicine and is especially important in a rapidly evolving field such as neurology. Due to improved imaging techniques and laboratory testing, ...
Incidence and prevalence of headache in influenza: A 2010-2021 surveillance-based study [0.03%]
基于监测的2010至2021年流感头痛发病率和患病率研究
David García-Azorín,Laura Santana-López,Ana Ordax-Díez et al.
David García-Azorín et al.
Background and purpose: Influenza is a common cause of acute respiratory infection, with headache being one of the symptoms included in the European Commission case definition. The prevalence of headache as a symptom of i...
Co-occurrence of glial fibrillary acidic protein astrocytopathy in a patient with Leber's hereditary optic neuropathy due to DNAJC30 mutations [0.03%]
LEBER遗传性视神经病变伴DNAJC30突变患者的胶质纤维酸性蛋白星形胶质细胞病共病一例
Maria Pia Giannoccaro,Luana Morelli,Fortuna Ricciardiello et al.
Maria Pia Giannoccaro et al.
Leber's hereditary optic neuropathy (LHON) is a mitochondrial disease characterized by visual loss, and rarely associated with extraocular manifestations including multiple sclerosis-like lesions. The association of LHON and neuromyelitis o...
Case Reports
European journal of neurology. 2024 May 17:e16344. DOI:10.1111/ene.16344 2024
Low caveolin-1 levels and symptomatic intracranial haemorrhage risk in large-vessel occlusive stroke patients after endovascular thrombectomy [0.03%]
低 Caveolin-1 水平与大血管闭塞性卒中患者取栓术后的有症状颅内出血风险的关系
Yi Xie,Min Wu,Yun Li et al.
Yi Xie et al.
Background and purpose: Caveolin-1 (Cav-1) is reported to mediate blood-brain barrier integrity after ischaemic stroke. Our purpose was to assess the role of circulating Cav-1 levels in predicting symptomatic intracranial...
Guillain-Barré syndrome: History, pathogenesis, treatment, and future directions [0.03%]
吉兰-巴雷综合征：历史、发病机制、治疗及未来方向
Richard A C Hughes
Richard A C Hughes
Background and purpose: Since its description by Guillain, Barré, and Strohl in 1916, Guillain-Barré syndrome (GBS) has attracted a large literature. The author reviews the history of research into its pathogenesis and ...
"Spanish flu," encephalitis lethargica, and COVID-19: Progress made, lessons learned, and directions for future research [0.03%]
“西班牙流感”、脑炎后帕金森综合征和新冠肺炎：已取得的进展，得到的经验教训及未来的研究方向
Michael Brainin,Yvonne Teuschl,Ellen Gelpi
Michael Brainin
One hundred years ago, an influenza pandemic swept across the globe that coincided with the development of a neurological condition, named "encephalitis lethargica" for the occurrence of its main symptom, the sudden onset of sleepiness that...
Validity of the Short Weekly Calendar Planning Activity in patients with Parkinson disease and nonmanifesting LRRK2 and GBA carriers [0.03%]
帕金森病患者及携带LRRK2和GBA基因突变但未发病患者短期周历计划活动有效性的验证研究
Tamara Schejter-Margalit,Noam Ben Binyamin,Avner Thaler et al.
Tamara Schejter-Margalit et al.
Background and purpose: Subtle executive dysfunction is common in people newly diagnosed with Parkinson disease (PD), even when general cognitive abilities are intact. This study examined the Short Weekly Calendar Plannin...
Blood pressure variability in acute stroke: Risk factors and association with functional outcomes at 1 month [0.03%]
急性脑卒中患者血压变异性的危险因素及1个月功能预后的影响
Catriona Reddin,Robert Murphy,Graeme J Hankey et al.
Catriona Reddin et al.
Background and purpose: Blood pressure variability, in acute stroke, may be an important modifiable determinant of functional outcome after stroke. In a large international cohort of participants with acute stroke, it was...
Diverging medical and legal perceptions of the need for legal guardianship in people with dementia: A qualitative study [0.03%]
痴呆患者法律监护必要性的医学与法学观点分歧：定性研究
Kaisa Näkki,Anna Mäki-Petäjä-Leinonen,Kaijus Ervasti et al.
Kaisa Näkki et al.
Background: Dementia is assumed to alter mental capacity, which may necessitate legal guardianship. However, only limited research exists on how dementia affects mental capacity, and most studies have focused solely on a ...
A multicenter, randomized, open-label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis [0.03%]
托利珠单抗治疗成人全身型重症肌无力的多中心、随机、开放标签、Ⅱ期临床研究
Jian Yin,Mingming Zhao,Xianhao Xu et al.
Jian Yin et al.
Background and purpose: This study aimed to investigate the clinical efficacy and safety of telitacicept in patients with generalized myasthenia gravis (gMG) who tested positive for acetylcholine receptor antibodies or mu...
Clinical Trial
European journal of neurology. 2024 Aug;31(8):e16322. DOI:10.1111/ene.16322 2024